Literature DB >> 7104174

Digitoxin accumulation.

H R Ochs, J Pabst, D J Greenblatt, J Hartlapp.   

Abstract

1 Nine healthy volunteers received single 1 mg intravenous doses of digitoxin, following which serum digitoxin concentrations were measured at multiple points in time over the next 14 days. 2 Mean kinetic variables for digitoxin were: volume of distribution, 0.76 l/kg; elimination half-life, 8 days; total clearance, 0.049 ml min-1 kg-1. 3 After a drug-free interval of at least 4 months, subjects took 0.07 mg of oral digitoxin daily for 28 consecutive days. Serum digitoxin concentrations were measured during the period of dosage and in the 21 day post-dosage washout. 4 Digitoxin accumulation was slow, proceeding with a mean half-life (7.9 days) that was nearly identical to the single-dose half-life. However, the two were not significantly correlated. 5 Mean observed steady-state serum concentrations (15.4 ng/ml) also were nearly identical to those predicted from the single-dose study (15.3 ng/ml), but again the two were not significantly correlated. 6 Steady state is very slowly attained after initiation of maintenance therapy with digitoxin. The kinetic data suggest that a loading dose on the average should be 12 times the maintenance dose.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7104174      PMCID: PMC1427752          DOI: 10.1111/j.1365-2125.1982.tb01966.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Drug therapy. Clinical Pharmacokinetics (first of two parts).

Authors:  D J Greenblatt; J Kock-Weser
Journal:  N Engl J Med       Date:  1975-10-02       Impact factor: 91.245

2.  Clinical pharmacokinetics of digitoxin.

Authors:  D Perrier; M Mayersohn; F I Marcus
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 3.  Predicting steady state serum concentrations of drugs.

Authors:  D J Greenblatt
Journal:  Annu Rev Pharmacol Toxicol       Date:  1979       Impact factor: 13.820

4.  Radioimmunoassay for serum digitoxin concentration: methodology and clinical experience.

Authors:  T W Smith
Journal:  J Pharmacol Exp Ther       Date:  1970-11       Impact factor: 4.030

5.  Noninteraction of digitoxin and quinidine.

Authors:  H R Ochs; J Pabst; D J Greenblatt; H J Dengler
Journal:  N Engl J Med       Date:  1980-09-18       Impact factor: 91.245

6.  Single- and multiple-dose kinetics of intravenous digoxin.

Authors:  H R Ochs; D J Greenblatt; G Bodem
Journal:  Clin Pharmacol Ther       Date:  1980-09       Impact factor: 6.875

7.  Interindividual differences in the pharmacokinetics of digitoxin and digoxin during long-term treatment.

Authors:  K O Haustein
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

  7 in total
  4 in total

1.  Single and multiple dose kinetics of clobazam, and clinical effects during multiple dosage.

Authors:  H R Ochs; D J Greenblatt; M Lüttkenhorst; B Verburg-Ochs
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

2.  Effect of plasma exchange on the steady-state kinetics of digoxin and digitoxin.

Authors:  F Keller; G Kreutz; H F Vöhringer; G Offermann; A Distler
Journal:  Clin Pharmacokinet       Date:  1985 Nov-Dec       Impact factor: 6.447

3.  Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam, and oxazepam.

Authors:  D J Greenblatt; V H Sethy
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 4.  Quo vadis Cardiac Glycoside Research?

Authors:  Jiří Bejček; Michal Jurášek; Vojtěch Spiwok; Silvie Rimpelová
Journal:  Toxins (Basel)       Date:  2021-05-11       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.